RCUS Stock | | | USD 17.42 0.05 0.29% |
Arcus Biosciences financial indicator trend analysis is way more than just evaluating Arcus Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arcus Biosciences is a good investment. Please check the relationship between Arcus Biosciences Change To Account Receivables and its End Period Cash Flow accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Arcus Stock please use our
How to Invest in Arcus Biosciences guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Arcus Biosciences Change To Account Receivables account and
End Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.
The correlation between Arcus Biosciences' Change To Account Receivables and End Period Cash Flow is 0.63. Overlapping area represents the amount of variation of Change To Account Receivables that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Arcus Biosciences, assuming nothing else is changed. The correlation between historical values of Arcus Biosciences' Change To Account Receivables and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Account Receivables of Arcus Biosciences are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Account Receivables i.e., Arcus Biosciences' Change To Account Receivables and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Most indicators from Arcus Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arcus Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Arcus Stock please use our
How to Invest in Arcus Biosciences guide.At this time, Arcus Biosciences'
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 6.3
M in 2024, despite the fact that
Enterprise Value Over EBITDA is likely to grow to
(4.36).
When running Arcus Biosciences' price analysis, check to
measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to
predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.